NicolePChappellMDFACOG, FACS(She/Her)

PubMed

• A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope.
  Erin E Grundy, Lauren C Shaw, Loretta Wang, Abigail V Lee, James Castro Argueta
  Mobile DNA. 2024-10-09
• 1 citations
  Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
  Calen W Kucera, Nicole P Chappell, Chunqiao Tian, Michael T Richardson, Christopher M Tarney
  Gynecologic Oncology. 2024-05-01
• 1 citations
  Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer-Accredited Facilities in the United St...
  Collin A Sitler, Chunqiao Tian, Chad A Hamilton, Michael T Richardson, John K Chan
  Cancers. 2024-03-06

Journal Articles

• Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user  
  Jaegle WT, Barnett JC, Stralka BR, Chappell, NP, Gynecologic Oncology Reports, 1/31/2017
• Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GO...  
  Miller CR, Chappell NP, Sledge C, Leath CA 3rd, Phippen NT, Havrilesky LJ, Barnett JC, Gynecol Oncol, 1/1/2017
• Actinomyces-Related Tubo-Ovarian Abscess in a Poorly Controlled Type II Diabetic With a Copper Intrauterine Device  
  Sawtelle AL, Chappell NP, Miller CR, Mil Med, 1/1/2017
• Is FDA Approved Bevacizumab Cost-Effective in the Setting of Platinum-Resistant Recurrent Ovarian Cancer?  
  Chappell NP, Miller C, Barnett J, Fielden A, Obstet Gynecol, 1/1/2016
• Is FDA-approved Bevacizumab cost-effective when included in the treatment of platinum-resistant recurrent ovarian cancer?  
  Chappell NP, Miller CR, Fielden AD, Barnett JC, J Oncol Pract, 1/1/2016
• Degenerating Uterine Fibroids Mimic Ovarian Dermoid Cysts in a Postmenopausal Woman  
  Chappell, NP, Irisari I, J of Minim Invasive Gynecol, 1/1/2010
• Join now to see all

Abstracts/Posters

• Histology matters in developing a framework for explaining racial disparity in cervical cancer survival.
  Chappell NP, Rojas C, Casablanca G, Maxwell LG, Hamilton C, Darcy K, SGO Winter Meeting on Women's Cancer, Olympic Valley, CA, 1/1/2019
• Surgical Modalities and Differences in Outcome among Clinical Stage I Endometrial Cancer Patients in a Military Treatment Facility Compared to Civilian Hospitals.
  Cooper D, Chappell NP, Phippen N, Jaeger A, Annual District Meeting, Armed Forces District, ACOG, Honolulu, HI, 1/1/2018
• Right Atrial Thrombus During Cisplatin-based Combination Chemotherapy of Ovarian Yolk Sac Tumor: An Unusual Case Report.
  Jaeger A, Phippen N, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Honolulu, HI, 1/1/2018
• Key Components for Implementation of a Structured Enhanced Recovery after Surgery (ERAS) Program at a Military Treatment Facility: a Novel Order Set and Multi-discipli...
  Chappell NP, Kallingal G, McKinlay A, Mielke RA, Saunders R, 2018 American College of Surgeons Quality and Safety Conference, Orlando, FL, 1/1/2018
• Quality Improvement and Patient Safety: A Faculty Development and Involvement Plan.
  Cox-Bauer CM, Keyser EA, Chappell NP, CREOG & APGO Meeting, National Harbor, MD, 1/1/2018
• Implementing ERAS: A pilot patient group in the department of Gynecology.
  Parson A, Storey J, DeAssis V, Shumbusho D, Chappell NP, SAUSHEC Patient Safety Week, San Antonio, TX, 1/1/2017
• Itchy Vulva: A Case of invasive vulvar melanoma.
  DeAssis V, Chappell NP, SAUSHEC Resident Research Day, San Antonio, TX, 1/1/2017
• Polypoid Endometriosis mimicking Invasive Cancer in an Obese, Postmenopausal Tamoxifen User.
  Jaegle TW, Barnett JC, McGovern BR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Case Study: Unusual presentation of Sertoli-Leydig cell ovarian tumor.
  Fett K, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Acute Urinary Retention Leading to Diagnosis of Uterine Incarceration at 13 weeks.
  Sledge, C. Fielden A., Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Cervical Endometriosis Found During Treatment for Cervical Dysplasia.
  Wavers K, Miller CR, Chappell, NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Is FDA approved bevacizumab cost-effective when included in treatment of platinum-resistant recurrent ovarian cancer?
  Chappell NP, Miller CR, Fielden AD, Barnett JC, SAUSHEC Resident Research Day, San Antonio, TX, 1/1/2015
• Forniceal rupture secondary to a symptomatic fibroid uterus, a case report.
  Davila K, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Case report of an extra-gonadal retroperitoneal mature teratoma in a perimenopausal female.
  Wavers K, Simoni C, Chappell NP, Miller CR, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Coming Full Circle: Actinomyces related tubo-ovarian abscess in an immunosuppressed patient with a copper IUD.
  Sawtelle A, Chappell NP, Miller CR, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Are different methotrexate regimens as first line therapy for low gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174.
  Miller CR., Chappell NP, Leath III CA., Phippen, NT, Havrilesky, LJ., Barnett, JC, Annual Meeting on Women's Cancer, Society of Gynecologic Oncology, Chicago, IL, 1/1/2015
• Proteomic profiling of stage I endometrial cancers: an attempt to identify a signature of early stage recurrence in GOG 8016.
  Chappell NP, Mieznikowski J, Shepherd L, Ramirez, N, Wallace AH, Rose SG, Wang G, Hood BL, Casablanca, G, Berchuck A, Havrilesky L, Darcy K , Hamilton,CA, Conrads TP, ..., Annual Meeting on Women's Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/1/2014
• Proteomics-based Comparative Analysis of Mitochondria Isolated from Human Cisplatin-sensitive and Resistant Ovarian Carcinoma Cell Lines
  Chappell, NP, Teng, PN, Hood, B, Hamilton CA, Maxwell, GL, Conrads, TP, American Association for Cancer Research, Chicago, IL, 1/1/2012
• Mitochondrial Proteome in Cisplatin Resistant Ovarian Cancer Cell Lines.
  Chappell, NP, Conrads, TP, Teng PN, Hood, B. Maxwell GL, Annual District Meeting, Armed Forces District, ACOG, San Diego, CA, 1/1/2011
• Join now to see all

Lectures

• Key Components for Implementing an Enhanced Recovery After Surgery Program in Gynecologic Surgery at a Military Treatment Facility: Creation of a Novel Order Set and M... 
  Honolulu, HI - 1/1/2018
• Implementation of a Structured Enhanced Recovery after Surgery Program: Assessment of Surgical Quality Improvement Outcomes for Hysterectomy Procedures at a Military T... 
  Orlando, FL - 1/1/2018
• Is FDA Approved Bevacizumab cost-effective in the setting of platinum-resistant recurrent ovarian cancer? 
  Washington, DC - 1/1/2016
• The Molecular Basis of Estrogen-Dependent Disorders: A DNA study to Screen for Polymorphisms or Mutations Resulting in Estrogen Excess 
  Louisville, KY - 1/1/2008
• Join now to see all